Data gathered: May 30
AI Stock Analysis - 2Seventy Bio (TSVT)
Analysis generated September 26, 2024. Powered by Chat GPT.
2Seventy Bio is a biopharmaceutical company focused on advancing transformative gene therapy treatments for patients, particularly in oncology. The company emphasizes innovation in developing novel therapies aimed at addressing unmet medical needs. Emerging from the competitive biotech and pharmaceuticals sector, 2Seventy Bio has shown potential through its ongoing research and pipeline of products targeting critical areas in cancer treatment.
Stock Alerts - 2Seventy Bio (TSVT)
 |
2Seventy Bio | May 13 Business Outlook among employees is down by 4.6% over the last month. |
|
2Seventy Bio | March 20 Insider Alert: Snow Jessica is selling shares |
|
2Seventy Bio | March 14 Insider Alert: Kynam Capital Management GP, LLC is selling shares |
|
2Seventy Bio | March 11 Price is up by 76.1% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for 2Seventy Bio
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 38 | Sign up | Sign up | Sign up |
| Webpage traffic | 4,000 | Sign up | Sign up | Sign up |
| Employee Rating | 78 | Sign up | Sign up | Sign up |
| Google Trends | 10 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Instagram Followers | 328 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 13,371 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,714 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| Youtube Subscribers | 19 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 21 | Sign up | Sign up | Sign up |
| Linkedin Employees | 110 | Sign up | Sign up | Sign up |
About 2Seventy Bio
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States.
| Price | $5.00 |
| Target Price | Sign up |
| Volume | 1,160,000 |
| Market Cap | $266M |
| Year Range | $2.3 - $5.21 |
| Dividend Yield | 0% |
| Analyst Rating | 25% buy |
| Industry | Biotechnology |
In the news
 |
Northern Trust Corp Has $1.20 Million Stock Position in 2seventy bio, Inc. (NASDAQ:TSVT)May 29 - ETF Daily News |
|
Deutsche Bank AG Sells 958,639 Shares of 2seventy bio, Inc. (NASDAQ:TSVT)May 26 - ETF Daily News |
|
2seventy bio, Inc. (NASDAQ:TSVT) Given Average Recommendation of “Reduce” by AnalystsMay 24 - ETF Daily News |
2seventy bio, Inc.(NasdaqGS: TSVT) dropped from S&P Global BMI IndexMay 12 - Finnhub |
|
2seventy bio, Inc.(NasdaqGS: TSVT) dropped from S&P TMI IndexMay 12 - Finnhub |
|
|
Barclays PLC Raises Stake in 2seventy bio, Inc. (NASDAQ:TSVT)May 12 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 23M | 8.8M | -5.9M | 480,000 | -2.5M | 0.010 |
| Q4 '24 | 2.9M | 8.8M | -5.9M | -20M | -21M | -0.306 |
| Q3 '24 | 14M | 5.8M | 7.8M | -9.9M | -12M | -0.190 |
| Q2 '24 | 9M | 3.5M | 5.5M | 25M | -18M | 0.450 |
| Q1 '24 | 12M | 6.6M | 5.8M | -53M | -47M | -1.010 |
Insider Transactions View All
| Eatwell Victoria filed to sell 444,387 shares at $4.9. March 19 '25 |
| Baird William D III filed to sell 1,121,034 shares at $4.9. March 19 '25 |
| Snow Jessica filed to sell 254,193 shares at $4.9. March 19 '25 |
Similar companies
Read more about 2Seventy Bio (TSVT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of 2Seventy Bio?
The Market Cap of 2Seventy Bio is $266M.
What is the current stock price of 2Seventy Bio?
Currently, the price of one share of 2Seventy Bio stock is $5.00.
How can I analyze the TSVT stock price chart for investment decisions?
The TSVT stock price chart above provides a comprehensive visual representation of 2Seventy Bio's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling 2Seventy Bio shares. Our platform offers an up-to-date TSVT stock price chart, along with technical data analysis and alternative data insights.
Does TSVT offer dividends to its shareholders?
As of our latest update, 2Seventy Bio (TSVT) does not offer dividends to its shareholders. Investors interested in 2Seventy Bio should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of 2Seventy Bio?
Some of the similar stocks of 2Seventy Bio are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.